Month: September 2022

BEIJING, Sept. 06, 2022 (GLOBE NEWSWIRE) — China Index Holdings Limited (NASDAQ: CIH), (“CIH” or the “Company”), a leading real estate information and analytics service platform provider in China, today announced (i) that its board of directors (the “Board”) has formed a special committee (the “Special Committee”) consisting of two independent directors, Mr. Jianping Ye and Mr. Jason Chenyang Wei, to evaluate and consider the previously announced preliminary non-binding acquisition proposal letter dated August 23, 2022 (the “Proposal”) from Fang Holdings Limited (“Fang”) to acquire all of the outstanding shares of the Company not currently owned by Fang (the “Proposed Transaction”), or any potential alternative transactions, and (ii) that the Special Committee has retained Gibson, Dunn & Crutcher LLP as its U.S. legal counsel...

                WisdomTree Issuer plc – Daily Fund Prices 06–September-22WisdomTree Battery Solutions UCITS ETF – USD Acc 05/09/2022 IE00BKLF1R75 9252534 USD 356,475,629.93 38.5274WisdomTree BioRevolution UCITS ETF – USD ACC 05/09/2022 IE000O8KMPM1 100000 USD 1,940,596.61 19.406WisdomTree Emerging Markets Equity Income UCITS ETF 05/09/2022 IE00BQQ3Q067 2737271 USD 35,440,427.71 12.9474WisdomTree Emerging Markets Equity Income UCITS ETF Acc 05/09/2022 IE00BDF12W49 160396 USD 3,216,521.04 20.0536WisdomTree Emerging Markets ex-State-Owned Enterprises ESG Screened UCITS ETF – USD Acc 05/09/2022 IE00BM9TSP27 120000 USD 2,230,320.37 18.586WisdomTree Emerging Markets Small Cap Dividend UCITS ETF 05/09/2022 IE00BQZJBM26 1880000 USD 31,576,750.42 16.7961WisdomTree EUR Aggregate Bond ESG Enhanced...

NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) — MarketAxess Holdings Inc. (Nasdaq: MKTX), the operator of a leading electronic trading platform for fixed-income securities, and the provider of market data and post-trade services for the global fixed-income markets, today announced monthly trading volume for August 2022.Chris Concannon, President and COO of MarketAxess commented: “A 27% year-over-year increase in total credit ADV and a 55% increase in U.S. Treasury ADV led to our best August results on record. Improved credit trading conditions and solid market share gains in our international product areas led to the strong volume growth in August. Open Trading estimated transaction cost savings3 were a total of $90 million in August, which equates to approximately $1,155 per million saved for our clients. Year-to-date estimated...

SANTA BARBARA, CA, Sept. 06, 2022 (GLOBE NEWSWIRE) — SunHydrogen, Inc. (OTC: HYSR), the developer of a breakthrough technology to produce renewable hydrogen using sunlight and water, today provided a first look at the prototype design for its forthcoming nanoparticle-based green hydrogen technology. The images can be viewed by visiting the Company’s news feed. “Within an individual SunHydrogen panel, billions of microscopic nanoparticles are splitting apart water at the molecular level to produce hydrogen and oxygen,” said SunHydrogen’s Chief Scientific Officer Dr. Syed Mubeen. “What you see in the rendered images is a single prototype panel contained in protective housing,” Dr. Mubeen continued. “In a future hydrogen production plant or farm, our panels would be scaled up in dimension to form a larger, more powerful array. Essentially,...

NEWTOWN, Pa., Sept. 06, 2022 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that Dane Andreeff, President and Chief Executive Officer, and Jeff Mathiesen, Chief Financial Officer, will present at two upcoming healthcare conferences as follows:H.C. Wainwright 24th Annual Global Investment Conference (Virtual) Dates:   Monday, September 12, 2022 – Wednesday, September 14, 2022     Time:    On demand, beginning at 7:00 AM ET*     * For H.C. Wainwright Conference registrants. Ladenburg Thalmann 2022 Healthcare Conference (New York City) Date:   Thursday, September 29, 2022     Time:   10:00 AM ETAbout Helius Medical Technologies, Inc.Helius Medical Technologies is a leading...

SAN DIEGO, Sept. 06, 2022 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today announced that the company’s management team will be presenting and participating in one-on-one meetings at the H.C. Wainwright 24th Annual Global Investment Conference, which is taking place both virtually and at the Lotte New York Palace Hotel in New York City, September 12-14, 2022. Investors who are interested in meeting with Biora at the conference should reach out to their H.C. Wainwright representative to schedule a meeting. About Biora TherapeuticsBiora Therapeutics is the biotech company that is reimagining therapeutics. By creating innovative smart pills designed for targeted drug delivery to the GI tract, and systemic, needle-free delivery of biotherapeutics, the company is...

CAMBRIDGE, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) — Cerevel Therapeutics, (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced that members of the management team will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022. Chairperson and Chief Executive Officer Tony Coles, M.D., will participate in a fireside chat at 9:20AM ET. The live webcast of the fireside chat can be accessed on the investor relations section of the Cerevel Therapeutics website here. A replay will be available in the same section of the company’s website. About Cerevel TherapeuticsCerevel Therapeutics is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. The company is tackling diseases with a targeted approach...

GAITHERSBURG, Md., Sept. 06, 2022 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has dosed the first participant in its Phase 1 study evaluating the safety and immunogenicity of EBS-LASV, a recombinant VSV-vectored Lassa virus vaccine candidate being developed for prevention of disease caused by Lassa virus infection. Emergent and CEPI (the Coalition for Epidemic Preparedness Innovations) are co-funding this program. “Over the last 24 years, Emergent’s mission to protect and enhance life and commitment to help mitigate public health threats have remained unchanged,” said Kelly Warfield, Ph.D., SVP for research and development at Emergent BioSolutions. “We are proud to deploy our product development and partnering capabilities to address emerging infectious diseases like Lassa fever, for which...

GZ Networks Seeks Partnership Opportunities with Hotels and Restaurants LAS VEGAS, NV, Sept. 06, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Green Zebra Networks, a division of GZ6G Technologies, Corp. (OTCQB: GZIC), focuses on IT advisory services, IT networking and IT managed services for small to medium size businesses in Southern California. Green Zebra Networks also supports GZ6G national enterprise clients with IT networking, cybersecurity solutions, 24/7 help desk, monitoring and managed services and Products. GZ6G Technologies, Corp. OTCQB: GZIC, a global smart technology solutions advisor and provider for smart stadiums, universities, airports, hospitality and smart city projects, offering enterprise smart solution advisory services, smart products and services to its clients. The Company helps enterprise clients that lack...